NCT00042588View on ClinicalTrials.gov

A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2002

Conditions
PneumoniaSepsis
Interventions
DRUG

Recombinant Chimeric Monoclonal Antibody

Trial Locations (1)

98021

ICOS Corporation, Bothell

Sponsors

Lead Sponsor

ICOS Corporation
All Listed Sponsors
lead

ICOS Corporation

INDUSTRY